Expert Insights on the Value of Protection Against Vaccine-Preventable Disease in Patients with Diabetes

16:30 – 16:35Welcome and Introduction
16:35 – 16:45Burden and Outcomes of Vaccine-Preventable Diseases in Patients with Diabetes
16:45 – 17:05Preventing Severe Outcomes of RSV Infection in Patients with Diabetes: A Case Study
17:05 – 17:25Maintaining Baseline through Herpes Zoster Prevention in Patients with Diabetes: A Case Study
17:25 – 17:40Preventing RSV and HZ in Patients with Diabetes: Guideline Recommendations and Implementation Considerations
17:40 – 17:50Panel Discussion
17:50 – 18:00Q&A and Closing Remarks